Brown Advisory’s Teva Pharmaceutical Industries TEVA Stock Holding History
Bought
Maintained
Sold
Other funds holding TEVA
Brown Advisory's TEVA Position: Q2 2019 in Review
Brown Advisory sold out of Teva Pharmaceutical Industries (TEVA) in Q2 2019, closing a stake of 84,989 shares — an estimated $1.33M sold.
Brown Advisory first reported a position in TEVA in Q2 2013 and held it in 21 quarters. The position peaked at $212M in Q4 2015. 450 funds tracked by Wall St. Rank hold TEVA as of Q2 2019.
- Brown Advisory reported no remaining Teva Pharmaceutical Industries position as of Q2 2019 after selling out during the quarter.
- Brown Advisory sold 84,989 Teva Pharmaceutical Industries shares in Q2 2019, an estimated $1.33M.
- Brown Advisory first reported a position in Teva Pharmaceutical Industries in Q2 2013 and held it in 21 quarters.
- Brown Advisory's Teva Pharmaceutical Industries position peaked at $212M in Q4 2015.
- 450 funds tracked by Wall St. Rank held Teva Pharmaceutical Industries as of Q2 2019.
Based on Brown Advisory's 13F filing for Q2 2019, filed 12 Aug 2019.